Bristol-Myers Squibb will acquire Celgene in blockbuster $74B deal
KRISTOFFER TRIPPLAAR/SIPA VIA AP
The transaction between biopharma giants joins two of the largest companies in oncology, both of which have been facing setbacks.
Sols 4345-4347: Contact Science is Back on the Table
Hace 21 horas
.jpeg)
No hay comentarios:
Publicar un comentario